The Business Times
SUBSCRIBERS

GSK eyes support from Singapore, Qatar for consumer healthcare division

google-preferred-sourceAdd BT as a preferred source
Published Tue, Jan 18, 2022 · 09:50 PM

    London

    GLAXOSMITHKLINE (GSK) is spinning off its consumer healthcare division this year, and intends to seek support for the flotation from sovereign wealth funds and other major institutions.

    A report in The Telegraph on Monday (Jan 17) said that Singapore and Qatar were regarded as potential "cornerstone investors".

    Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.

    GlaxoSmithKlineGIC

    Copyright SPH Media. All rights reserved.

    Reuse this contentFeedback
    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More